Clinical Trial Update: A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 study of temsirolimus in combination with bevacizumab for recurrent glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED